Patents by Inventor Franz Fridolin Hefti

Franz Fridolin Hefti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of an NK-1 receptor antagonist and an SSRI for treating obesity
    Patent number: 6162805
    Abstract: The present invention relates to the use of an NK-1 receptor antagonist and a selective serotonin reuptake inhibitor for the treatment or prevention of obesity.
    Type: Grant
    Filed: October 22, 1999
    Date of Patent: December 19, 2000
    Assignee: Merck Sharp & Dohme Limited
    Inventor: Franz Fridolin Hefti
  • Antispastic use of triazolo-pyridazine derivatives
    Patent number: 6046196
    Abstract: A class of substituted 7,8-ring fused 1,2,4-triazolo[4,3-b]pyridazine derivatives, as shown in Formula I possessing an optionally substituted cycloalkyl, phenyl or heteroaryl substituent at the 3-position and a substituted alkoxy moiety at the 6-position, are selective ligands for GABA.sub.A receptors, in particular having high affinity for the .alpha.2 and/or .alpha.3 subunit thereof, and are accordingly of benefit in the treatment and/or prevention of muscle spasm or spasticity, e.g. in paraplegic patients.
    Type: Grant
    Filed: December 9, 1998
    Date of Patent: April 4, 2000
    Assignee: Merck Sharp & Dohme Ltd.
    Inventor: Franz Fridolin Hefti